Bausch + Lomb Ireland in the news

Winning the 2026 Contact Lens Award, the Ultra portfolio expanded its off-the-shelf parameters to better support independent practitioners and patient acquisition.

Major corporations including Bausch + Lomb are suing the U.S. government for refunds following a Supreme Court ruling against Trump-era tariffs.

Mark Draper will lead vision care operations and strategic growth in the UK, Ireland, and Nordics starting in 2026.

New Ultra One Day Multifocal daily disposable silicone hydrogel contact lenses have been launched in the UK and Ireland.

Mark Draper has been appointed as the new business unit director for Vision Care in the UK, Ireland, and Nordics to lead regional growth and product launches.

Bausch + Lomb's Waterford campus integrates global R&D and high-scale manufacturing to develop next-generation contact lens technologies and bioactive materials.

Bausch + Lomb is expanding its Waterford and Rochester manufacturing hubs to produce a new pipeline of next-generation contact lenses through 2029.

Bausch + Lomb is investing $765 million in its Irish manufacturing operations to expand production despite global tax and tariff concerns.

A milestone anniversary marks the expansion of the Waterford eye health facility into a global manufacturing leader with 1,600 employees.

Bausch + Lomb Ireland saw 2023 pre-tax losses widen to $959.7 million due to high R&D spending and the $1.75 billion acquisition of XIIDRA.

Bausch + Lomb is exploring a potential sale as part of its ongoing separation from Bausch Health, amid recent stock volatility and reported private equity interest.

A €90 million expansion of the Waterford facility will create 130 new jobs to increase contact lens production capacity.

Bausch + Lomb manages a nationwide recycling initiative for contact lens waste that upcycles materials into community infrastructure while supporting global vision charities.

Bausch Health is exploring a potential sale or spinoff of Bausch + Lomb to private equity or public markets to reduce corporate debt while maintaining global manufacturing operations.

A large-scale nitrogen generation plant was installed at the Waterford manufacturing site to ensure self-sufficiency and reduce carbon emissions from liquid nitrogen deliveries.

A new high-purity nitrogen generation plant has been installed at the Waterford facility to ensure self-sufficiency and support manufacturing expansions.

Bausch + Lomb is expanding its contact lens manufacturing capacity in Rochester and Waterford through a four-year investment program.

Bausch + Lomb is adding over 200 jobs through a manufacturing expansion at its Rochester and Waterford contact lens facilities.

Bausch + Lomb is expanding its Rochester and Waterford manufacturing facilities to produce new silicone hydrogel contact lenses and create 100 new jobs.

Staff at the Waterford plant are voting on a 9.5 percent pay rise and improved benefits following a dispute between Siptu and management.